Etiology of pediatric ischemic stroke

American Journal of Emergency Medicine

Volumn 15, Issue 7, 1997, Pages 671-679

  Ferrera, Peter C ^a   Curran, Carrol B ^a   Swanson, Holly ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

AIDS; Anticardiolipin antibodies; Antiphospholipid antibodies; Ischemic stroke; Lupus enticoagulant; MELAS; Migrainous stroke; Moyamoya disease; Pediatric; Protein C and S deficiency; Sickle cell disease

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CEREBROVASCULAR ACCIDENT; CHILD; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; HUMAN; MELAS SYNDROME; MIGRAINE; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; SICKLE CELL ANEMIA;

EID: 0030666356     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(97)90183-2     Document Type: Review

References (126)

1. Schoenberg BS, Mellinger JF, Schoenberg DG: Cerebrovascular disease in infants and children: A study of incidence, clinical features, and survival. Neurology 1978;28:763-768
2. Hindfelt B, Nilsson O: Brain infarction in young adults. Acta Neurol Scand 1977;55:145-157
3. Riela AR, Roach ES: Etiology of stroke in children. J Child Neurol 1993;8:201-220
4. Trescher WH: Ischemic stroke syndromes in childhood. Pediatr Ann 1992;21:374-383
5. Martelle RR, Linde LM: Cerebrovascular accidents with tetralogy of Fallot. Am J Dis Child 1961;101:206-209
6. Nagaraja D, Verma A, Taly AB, et al: Cerebrovascular disease in children. Acta Neurol Scand 1994;90:251-255
7. Dusser A, Goutieres F, Aicardi J: Ischemic strokes in children. J Child Neurol 1986;1:131-136
8. Lanska MJ, Lanska DJ, Horwitz SJ, et al: Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol 1991;7:333-341
9. Yang JS, Park YD, Hartlage PL: Seizures associated with stroke in childhood. Pediatr Neurol 1995;12:136-138
10. Kelley RE, Berger JR: Ischemic stroke in a girl with lupus anticoagulant. Pediatr Neurol 1987;3:58-61
11. Olson JC, Konkol RJ, Gill JC, et al: Childhood stroke and lupus anticoagulant. Pediatr Neurol 1994;10:54-57
12. Ozen S, Besbas N, Saatci U, et al: Diagnostic criteria for polyarteritis nodosa in childhood. J Pediatr 1992;120:206-209
13. Engel DG, Gospe SM Jr, Tracy KA, et al: Fatal infantile polyarteritis nodosa with predominant central nervous system involvement. Stroke 1995;26:699-701
14. Laxer RM, Dunn HG, Flodmark O: Acute hemiplegia in Kawasaki disease and infantile polyarteritis nodosa. Develop Med Child Neurol 1984;26:814-818
15. Lemahieu SF, Marchau MMB: Intracranial fibromuscular dysplasia and stroke in children. Neuroradiology 1979;18:99-102
16. Shields WD, Ziter FA, Osborn AG, et al: Fibromuscular dysplasia as a cause of stroke in infancy and childhood. Pediatrics 1977;59:899-901
17. Pavlakis SG, Gould RJ, Zito JL: Stroke in children. Adv Pediatr 1991;38:151-179
18. Chang V, Rewcastle NB, Harwood-Nash DCF, et al: Bilateral dissecting aneurysms of the intracranial carotid arteries in an 8-year-old boy. Neurology 1975;25:573-579
19. Nass R, Hays A, Chutorian A: Intracranial dissecting aneurysms in childhood. Stroke 1982;13:204-207
20. Patel H, Smith RR, Garg BP: Spontaneous extracranial carotid artery dissection in children. Pediatr Neurol 1995;13:55-60
21. Schievink WI, Mokri B, Piepgras DG: Spontaneous dissections of cervicocephalic arteries in childhood and adolescence. Neurology 1994;44:1607-1612
22. Parker P, Puck J, Fernandez F: Cerebral infarction associated with Mycoplasme pneumoniae. Pediatrics 1981;67:373-375
23. Roden VJ, Cantor HE, O'Connor DM, et al: Acute hemiplegia of childhood associated with Coxsackie A9 viral infection. J Pediatr 1975;86:56-58
24. Austin MG, Schaefer RF: Marfan's syndrome, with unusual blood vessel manifestations. Arch Pathol 1957;64:205-209
25. Schievink WI, Limburg M, Oorthuys JWE, et al: Cerebrovascular disease in Ehlers-Danlos syndrome type IV. Stroke 1990;21:626-632
26. Packer RJ, Rorke LB, Lange BJ, et al: Cerebrovascular accidents in children with cancer. Pediatrics 1985;76:194-201
27. Keidan I, Shahar E, Barzilay Z, et al: Predictors of outcome of stroke in infants and children based on clinical data and radiologic correlates. Acta Paediatr 1994;83:762-765
28. Bruno A, Yuh WTC, Biller J, et al: Magnetic resonance imaging in young adults with cerebral infarction due to moyamoya. Arch Neurol 1988;45:303-306
29. Suzuki J, Takaku A: Cerbrovascular "moyamoya" disease. Arch Neurol 1969;20:288-299
30. Rovira M, Torrent O, Ruscalleda J: Etiology of moya moya disease, acquired or congenital. Acta Radiol 1975;347:229-240 (suppl)
31. Schoenberg BS, Mellinger JF, Schoenberg DG: Moyamoya disease in children. South Med J 1978;71:237-241
32. Olds MV, Griebel RW, Hoffman HJ, et al: The surgical treatment of childhood moyamoya disease. J Neurosurg 1987;66:675-680
33. Karasawa J, Kikuchi H, Furuse S, et al: Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg 1978;49:679-688
34. Levin S: Moyamoya disease. Dev Med Child Neurol 1982;24: 850-853
35. Gordon N, Isler W: Childhood moyamoya disease. Dev Med Child Neurol 1989;31:103-107
36. Carlson CB, Harvey FH, Loop J: Progressive alternating hemiplegia in early childhood with basal arterial stenosis and telangiectasia (moyamoya syndrome). Neurology 1973;23:734-744
37. Numaguchi Y, Balsys R, Marc JA, et al: Some observations in progressive arterial occlusions in children and young adolescents: (Moyamoya disease). Surg Neurol 1976;6:293-300
38. Hilal SK, Solomon GE, Gold AP, et al: Primary cerebral arterial occlusive disease in children. Part II: Neurocutaneous syndromes. Radiology 1971;99:87-94
39. Taboada D, Alonso A, Moreno J, et al: Occlusion of the cerebral arteries in Recklinghausen's disease. Neuroradiology 1979; 18:281-284
40. Seeler RA, Royal JE, Powe L, et al: Moyamoya in children with sickle cell anemia and cerebrovascular occlusion. J Pediatr 1978;93: 808-810
41. Cohen N, Berant M, Simon J: Moyamoya and Fanconi's anemia. Pediatrics 1980;65:804-805
42. Schrager GO, Cohen SJ, Vigman MP: Acute hemiplegia and cortical blindness due to moya moya disease: Report of a case in a child with Down's syndrome. Pediatrics 1977;60:33-37
43. Lenn NJ, Pearson E: Moyamoya disease and other causes of stroke in Down's syndrome. Ann Neurol 1984;16:398 (abstr)
44. Goldstein EM, Singer HS: Moyamoya-like disease in Down's syndrome. Pediatr Neurosurg 1990-91;16:14-16
45. Berg JM, Armstrong D: On the association of moyamoya disease with Down's syndrome. J Mental Defic Res 1991;35:398-403
46. Handa J, Nakano Y, Okuno T, et al: Computerized tomography in moyamoya syndrome. Surg Neurol 1977;7:315-319
47. Houkin K, Aoki T, Takahashi A, et al: Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke 1994;25:2159-2164
48. Matsushima Y, Fukai N, Tanaka K, et al: A new surgical treatment of moyamoya disease in children: A preliminary report. Surg Neurol 1981;15:313-320
49. Amine ARC, Moody RA, Meeks W: Bilateral temporal-middle cerebral artery anastomosis for moyamoya syndrome. Surg Neurol 1977;8:3-6
50. Kurokawa T, Tomita S, Ueda K, et al: Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol 1985;1:274-277
51. Powars D, Wilson B, Imbus C, et al: The natural history of stroke in sickle cell disease. Am J Med 1978;65:461-471
52. Sarnaik SA, Lusher JM: Neurological complications of sickle cell anemia. Am J Pediatr Hematol Oncol 1982;4:386-394
53. Greer M, Schotland D: Abnormal hemoglobin as a cause of neurologic disease. Neurology 1962;12:114-123
54. Balkaran B, Char G, Morris JS, et al: Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992;120:360-366
55. Pavlakis SG, Prohovnik I, Piomelli S, et al: Neurologic complications of sickle cell disease. Adv Pediatr 1989;36:247-276
56. Pegelow CH, Adams RJ, McKie V, et al: Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995;126:896-899
57. Wood DH: Cerebrovascular complications of sickle cell anemia. Stroke 1978;9:73-75
58. Portnoy BA, Herion JC: Neurological manifestations in sickle-cell disease: With a review of the literature and emphasis on the prevalence of hemiplegia. Ann Intern Med 1972;76:643-652
59. Russell MO, Goldberg HI, Reis L, et al: Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. J Pediatr 1976; 88:382-387
60. Miller ST, Rieder RF, Rao SP, et al: Cerebrovascular accidents in children with sickle-cell disease and alpha-thalassemia. J Pediatr 1988;113:847-849
61. Jeffries BF, Lipper MH, Kishore PRS: Major intracerebral arterial involvement in sickle cell disease. Surg Neurol 1980;14:291-295
62. Greenberg J, Massey EW: Cerebral infarction in sickle cell trait. Ann Neurol 1985;18:354-355
63. Russell MO, Goldberg HI, Hodson A, et al: Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984;63:162-169
64. Sarnaik S, Soorya D, Kim J, et al: Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child 1979;133:1254-1257
65. Wilimas J, Goff JR, Anderson HR, Jr, et al: Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 1980;96:205-208
66. Cohen AR, Martin MB, Silber JH, et al: A modified transfusion program for prevention of stroke in sickle cell disease. Blood 1992;79:1657-1661
67. Hurlet-Jensen AM, Prohovnik I, Pavlakis SG, et al: Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease. Stroke 1994;25:1688-1692
68. Vermylen C, Ninane J, Fernandez-Robles E, et al: Bone marrow transplantation in five children with sickle cell anemia. Lancet 1988;1:1427-1428
69. Clark JM, Marks MP, Adalsteinsson E, et al: MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 1996;46:223-227
70. Goto Y, Horai S, Matsuoka T, et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-550
71. Hirano M, Pavlakis SG: Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): Current concepts. J Child Neurol 1994;9:4-13
72. Pavlakis SG, Phillips PC, DiMauro S, et al: Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome. Ann Neurol 1984;16:481-488
73. Riikonen R, Santavuori P: Hereditary and acquired risk factors for childhood stroke. Neuropediatrics 1994;25:227-233
74. Montagna P, Gallassi R, Medori R, et al: MELAS syndrome: Characteristic migrainous and epileptic features and maternal transmission. Neurology 1988;38:751-754
75. Hart ZH, Chang CH, Perrin EVD, et al: Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Arch Neurol 1977;34: 180-185
76. Goto Y: Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve 1995;Suppl 3:S107-S112
77. Tokunaga M, Mita S, Murakami T, et al: Single muscle fiber analysis of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Ann Neurol 1994;35:413-419
78. Sakuta R, Nonaka I: Vascular involvement in mitochondrial myopathy. Ann Neurol 1989;25:594-601
79. Peterson PL: The treatment of mitochondrial myopathies and encephalomyopathies. Biochim Biophys Acta 1995;1271:275-280
80. Koga SJ, Hodges M, Markin C, et al: MELAS syndrome. West J Med 1995;163:379-381
81. Centers for Disease Control: Unexplained immunodeficiency and opportunistic infections in infants - New York, New Jersey, California. MMWR Morbid Mortal Wkly Rep 1982;31:665-667
82. Centers for Disease Control: First 500,000 AIDS cases - United States, 1995. MMWR Morbid Mortal Wkly Rep 1995;44:849-853
83. Belman AL, Diamond G, Dickson D, et al: Pediatric acquired immunodeficiency syndrome: Neurologic syndromes. Am J Dis Child 1988;142:29-35
84. Belman AL, Ultmann MH, Horoupian D, et al: Neurological complications in infants and children with acquired immune deficiency syndrome. Ann Neurol 1985;18:560-566
85. O'Dell MW, Sasson NL: Hemiparesis in HIV infection: Rehabilitation approach. Am J Phys Med Rehabil 1992;71:291-296
86. Kieburtz KD, Eskin TA, Ketonen L, et al: Opportunistic cerebral vasculopathy and stroke in patients with the acquired immunodeficiency syndrome. Arch Neurol 1993;50:430-432
87. Engstrom JW, Lowenstein DH, Bredesen DE: Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am J Med 1989;86:528-532
88. Moriarty DM, Haller JO, Loh JP, et al: Cerebral infarction in pediatric acquired immunodeficiency syndrome. Pediatr Radiol 1994; 24:611-612
89. Park YD, Belman AL, Kim TS, et al: Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol 1990;28:303-311
90. Berger JR, Moskowitz L, Fischl M, et al: Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J 1987;80:683-686
91. Philippet P, Blanche S, Sebag G, et al: Stroke and cerebral infarcts in children infected with human immunodeficiency virus. Arch Pediatr Adolesc Med 1994;148:965-970
92. Bogousslavsky J, Regli F, Melle GV, et al: Migraine stroke. Neurology 1988;38:223-227
93. Bogousslavsky J, Pierre P: Ischemic stroke in patients under age 45. Neurol Clin 1992;10:113-124
94. Broderick JP, Swanson JW: Migraine-related strokes: Clinical profile and prognosis in 20 patients. Arch Neurol 1987;44:868-871
95. Connor RCR: Complicated migraine: A study of permanent neurological and visual defects caused by migraine. Lancet 1962;2: 1072-1075
96. Featherstone HJ: Clinical features of stroke in migraine: A review. Headache 1986;26:128-133
97. Henrich JB, Horwitz RI: A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 1989;42:773-780
98. Pereira Monteiro JM, Leite Carneiro A, Bastos Lima AF, et al: Migraine and cerebral infarction: Three case studies. Headache 1985;25:429-435
99. Rossi LN, Penzien JM, Deonna T, et al: Does migraine-related stroke occur in childhood? Dev Med Child Neurol 1990;32:1016-1021
100. Rothrock JF, Walicke P, Swenson MR, et al: Migrainous stroke. Arch Neurol 1988;45:63-67
101. Rothrock J, North J, Madden K, et al: Migraine and migrainous stroke: Risk factors and prognosis. Neurology 1993;43:2473-2476
102. Spaccavento LJ, Solomon GD: Migraine as an etiology of stroke in young adults. Headache 1984;24:19-22
103. Wober-Bingol C, Wober C, Karwautz A, et al: Migraine and stroke in childhood and adolescence. Cephalalgia 1995;15:26-30
104. Awerbuch G, Levin JR, Gupta R, et al: Ischemic stroke in childhood: A five-year review of twenty-eight cases. Ann Neurol 1989;26:478 (abstr)
105. Bartleson JD: Transient and persistent neurological manifestations of migraine. Stroke 1984;15:383-386
106. Welch KMA, Levine SR: Migraine-related stroke in the context of the international headcahe society classification of head pain. Arch Neurol 1990;47:458-462
107. Welch KMA: Relationship of stroke and migraine. Neurology 1994;44:S33-S36 (suppl 7)
108. Dorfman LJ, Marshall WH, Enzmann DR: Cerebral infarction and migraine: Clinical and radiologic correlations. Neurology 1979;29: 317-322
109. Ferrera PC, Reiche PR: Acute confusional migraine and trauma-triggered migraine. Am J Emerg Med 1996;14:276-278
110. Coull BM, Levine SR, Brey RL: The role of antiphospholipid antibodies in stroke. Neurol Clin 1992;10:125-143
111. Levine SR, Brey RL, Sawaya KL, et al: Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995;38:119-124
112. Schoning M, Klein R, Krageloh-Mann I, et al: Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood. Neuropediatrics 1994;25:8-14
113. Eby CS: A review of the hypercoagulable state. Hematol Oncol Clin North Am 1993;7:1121-1142
114. Harris EN, Gharavi AE, Hughes GRV: Antiphospholipid antibodies. Clin Rheum Dis 1985;11:591-609
115. Charles PD, Fenichel GM: Sneddon and antiphospholipid antibody syndromes causing bilateral thalamic infarction. Pediatr Neurol 1994;10:262-263
116. Roddy SM, Giang DW: Antiphospholipid antibodies and stroke in an infant. Pediatrics 1991;87:933-935
117. Angelini L, Ravelli A, Caporali R, et al: High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994;94:500-503
118. Devilat M, Toso M, Morales M: Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome. Pediatr Neurol 1993;9:67-70
119. Nuss R, Hays T, Manco-Johnson M: Childhood thrombosis. Pediatrics 1995;96:291-294
120. Brey RL, Hart RG, Sherman DG, et al: Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40:1190-1196
121. Babikian VL, Levine SR: Therapeutic considerations for stroke patients with antiphospholipid antibodies. Stroke 1992;23:I-33-I-37 (suppl I)
122. Khamashta MA, Cuadrado MJ, Mujic F, et al: The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-997
123. Allaart CF, Poort SR, Rosendaal FR, et al: Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993;341:134-138
124. Israels SJ, Seshia SS: Childhood stroke associated with protein C or S deficiency. J Pediatr 1987;111:562-564
125. Dusser A, Boyer-Neumann C, Wolf M: Temporary protein C deficiency associated with cerebral arterial thrombosis in childhood. J Pediatr 1988;113:849-851
126. Kennedy CR, Warner G, Kai M, et al: Protein C deficiency and stroke in early life. Dev Med Child Neurol 1995;37:723-730